RE: Something stirring29 Jan 2024 07:50
So I estimate cash position @ £2.1m vs a market cap of £700k
That’s a 200% gain to market cap & still be undervalued
Current costs will be a fraction of what they were before as there are no studies or live business occurring
Ovoca Bio are essentially a cash shell
On the day of the failed P2 studies, the share price dropped to 2.75p. Today, you can buy it under 1p
Multibagger